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Background/aim: This study aimed to develop the Nausea and Vomiting Thermometer Scale (NVTS) in children with cancer.
Materials and methods: This methodological study was conducted on 250 children with cancer at the research and training university
hospital in Turkey between September 2019 and January 2020. The t-test, the ROC analysis, the Diagnostic index, and the Youden index
were used for determining the scale of the cutting point. The regression analysis, the intra-class correlation coefficient, and the Bland–
Altman analysis were used for the data analysis.
Results: The scale-level content validity index was .94, which was coherent. As a result of the ROC analysis, the cut-off point was
determined as three points. The NVTS showed good reliability, with an intra-class correlation coefficient of .99. In the linear regression
analysis, a model was created for chemotherapy drugs, nausea and vomiting type, vomiting status, and the number of children with
cancer who vomited explained 44.9% of their nausea and vomiting status. The results of the Bland–Altman analysis showed that the
correlation coefficient between the differences and the means was insignificant.
Conclusion: The NVTS was found to be a valid and reliable measurement tool for children with cancer in the Turkish sample.
Key words: Nausea, vomiting, scale, children with cancer

1. Introduction
The new approaches used in the treatment of cancer
improve children’s recovery rate. However, these methods
can have various negative consequences on the child and
the family. The use of high-dose drugs in chemotherapy
causes children to experience many symptoms. Of these
symptoms, fatigue, pain, oral mucositis, nausea, and
vomiting are more common than the other symptoms
[1–3].
Nausea and vomiting are common symptoms in
children receiving cytotoxic chemotherapy. Many
mechanisms are involved in the development of nausea
and vomiting due to chemotherapy in children with
cancer, damage to the blood-brain barrier, impaired
gastrointestinal motility, and adrenal hormones [1,4]. The
emetic effect of chemotherapy agents is more common
in the first 24 h [5]. Uncontrolled nausea and vomiting
cause physical effects, such as dehydration, electrolyte
disturbance, malnutrition, gastrointestinal bleeding, and
aspiration pneumonia in children [6,7].
The prevention of symptoms improves the quality of
life of the child and contributes positively to treatment.
Nurses working in the field of pediatric oncology have

responsibilities for the evaluation, prevention, and
alleviation of the nausea and vomiting experienced by
children with cancer. Therefore, it is expected that evidencebased scientific knowledge obtained from research will be
applied to nursing practice through monitoring the latest
developments in this area. The first step in the prevention
or alleviation of symptoms is a detailed diagnosis of the
symptoms [4,8,9]. Therefore, the diagnosis of nausea and
vomiting, which have serious effects on quality of life and
treatment efficacy, is one of the most important factors
[10].
Children cannot express symptoms such as pain,
nausea, and vomiting, as adults do, due to language
development and cognitive deficits. This situation makes
the symptoms in children difficult to understand and
complicated [11]. With the preschool period, children
can use words and communicate to express the presence,
intensity and absence of symptoms. Therefore, they
can provide self-reporting, which is the most reliable
method. However, cognitive development has not yet been
completed in these children, as it continues until early
adulthood. Therefore, communication between healthcare
professionals and children is still limited due to language
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development or cognitive complexities. Therefore, the
use of visual scales is recommended [12]. In addition,
a scale should be accessible, easy to use, low cost and
understandable in clinical settings [13]. Therefore, it is
important to evaluate the symptoms with visual scales.
Because visual scales both provide a clear demonstration
of the symptom and are easy to apply, it prevents the loss
of time and workforce for clinicians. In the literature, there
is no cancer in children nausea and vomiting evaluating a
visual scale in Turkey.
There are several national and international scales that
evaluate nausea and vomiting in children with cancer [8].
Although there are studies for children to be assessed by
medical staff for nausea and vomiting in Turkey, no scale
has been developed specifically for children with cancer
[14,15]. This limits the ability of nurses caring for children
with cancer to diagnose nausea and vomiting symptoms
and plan appropriate interventions. There is a need for
a more reliable and valid tool for increasing the limited
number of studies in Turkey.
2. Methods
2.1. Purpose
The aim of this study was to develop the Nausea and
Vomiting Thermometer Scale (NVTS) in children who
have been diagnosed with cancer for between 5 and 18
years in Turkey.
2.2. Sample Population
This study was conducted between September 2019 and
January 2020 on children with cancer at the research
and training university hospital in Turkey. The sample
calculation was performed using the G*Power Software
statistical analysis program 3.1. The scale developed in this
study is not a Likert type scale, it is a visual analog type
scale. For this reason, the sample calculation was made
on the basis of regression analysis and ROC analysis. In
the literature, it has been reported that the four variables
that best determine nausea and vomiting in children with
cancer are the type of chemotherapy drug, the presence,
type and number of nausea and vomiting [4,5,15].
Considering the four variables to be used in the predictive
validity of the procedure based on regression analysis, the
effect size was calculated as 0.15 (medium), 80% power,
and a 0.05 significance level, and the required sample
size was 103 people. Considering a 10% loss, the sample
size was planned to be 115 children. For this reason, the
sampling involved 250 children aged between five and
eighteen who volunteered to participate in the study. In
this study, data were collected using the random sampling
method.
The research inclusion criteria: Children aged between
5 and 18 who were receiving chemotherapy in the Pediatric
Hematology-Oncology Clinic and Day Treatment Unit in

Turkey and who volunteered to participate in the study.
The research exclusion criteria were as follows: children
who did not volunteer to participate in the study and were
unconscious were not included.
2.3. Data Collection Tools
The child Information Form consists of seven questions
used to obtain descriptive data about the children, such as
their age, sex, diagnosis, chemotherapy drug, chemotherapy
day, nausea and vomiting type, and vomiting status.
2.3.1. Nausea and Vomiting Thermometer Scale
The literature was reviewed by the researcher, and general
and child-specific scales related to nausea and vomiting
were obtained. As a result of the literature review, a visual
scale was created to measure nausea and vomiting. The
scale is considered to be applicable and important for the
suitability of clinical use [8,15–17]. The scale is in the form
of a thermometer and has five ratings. An art director
supported the design of the scale. It is scored as follows:
never (1), rarely (2), occasionally (3), often (4), and always
(5). In addition, as the scale score increases, the facial
expressions on the scale changes. It shows: a smiley face
(1), a sad face (2), an unresponsive face (3), a nauseous
face (4), and a vomiting face (5). As the level of nausea and
vomiting increases, facial expression becomes unhappy on
the scale. For example, in the facial expression showing the
5th level, the child expresses his unhappiness by crying.
The lowest score is 1 and the highest is 5. An increase in
the score indicates an increase in the degree of nausea and
vomiting experienced by children with cancer (Figure 1).
2.3.2. Stage for forming item pool
According to Şimşek (2007), a detailed review should be
carried out on the variable that will be calculated during the
creation of the statements of the scale [18]. While forming
the item pool of the scale, we found studies defining the
nausea and vomiting scales in children with cancer. As a
result of our literature review, we formed dimensions to
determine the nausea and vomiting and developed item
pools for use with these dimensions [8,14–17].
2.3.3. Stage for Forming Specialist Opinions
At least 10 specialists recommended using a scale in
order to determine the content validity of the scales
[18]. We received the opinions of 11 specialists on the
scales (7 academic members from the Department of
Pediatric Nursing, 3 the Department of Oncology Nursing
members, and 1 the Department of Pediatrics member).
Specialists were given the scale type and asked to rate them
between 1 and 4 to determine the convenience of the scale
products (1 = requires a big shift, 4 = very convenient).
The final form of the scale is as a result of the input from
the specialists. The scores of the 11 experts were analyzed
with the validity review of material. Expert opinions were
evaluated by taking Davis technique into consideration.
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2.4.1. Validity
The content validity of the scale was evaluated by experts,
and the S-CVI was used in evaluating the expert opinions.
The t-test was used to compare the mean scores of children
with and without nausea and vomiting. The ROC analysis,
the Diagnostic index (DI) and the Youden index (YI) were
used for determining the scale of the cutting point. The
regression analysis was used for determining the criterion
or predictive validity [21].
2.4.2. Reliability
We used an intra-class correlation coefficient (ICC) for
determining the scale internal consistency [21]. The
Bland–Altman analysis was used to evaluate the difference
between the measurements taken by two different
evaluators.

Figure 1. The Nausea and Vomiting Thermometer Scale

2.5. Ethics Approval
The approval of the Ethics Committee of NonInterventional Research was obtained at the outset. In
order to carry out the study, institutional permits were
required. We also obtained written and verbal consent
from the children and their parents by visiting them
and reminding them of the study’s aims. The study was
conducted in compliance with the Helsinki Declaration
because the use of human beings in research includes the
preservation of individual rights.
3. Results

Davis technique grades expert opinions as (a) appropriate,
ure 1. The (b)
Nausea
Vomiting
Scale (c) item should be
itemandshould
be Thermometer
slightly reviewed,
seriously reviewed, and (d) item not suitable. In this
technique, the number of experts marking (a) and (b)
options is divided by the total number of experts, and the
content validity index for the item is obtained. Instead of
comparing it with a statistical criterion; a value of 0.80
is accepted as the criterion [19]. The scale-level content
validity index (S-CVI) is 0.99 and it is coherent.
2.3.4. Stage for forming preliminary test
Upon finding a match between the expert opinions, the
scale was piloted to 30 students. Since the scale was not
a concern with comprehensibility, it was considered
appropriate for wide-group management. After applying
the scale to a large group, the validity and accuracy test was
performed. In addition, the scale was applied separately by
two researchers at the same time [20].
2.4. Statistical Analysis
Data analysis was carried out using the IBM SPSS
Statistics 21.0 (Chicago, IL) package. The percentage and
mean scores for the descriptive statistics were used in the
data analysis. The error margin was set to p = 0.05 when
analyzing the data.
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3.1. Sample Characteristics
The sociodemographic characteristics of the children with
cancer who participated in the study are given in Table 1.
3.2. Validity Analyses
3.2.1. Content Validity
As a result of the specialists’ feedback on the draft scale,
11 expert opinions were obtained on the draft scale.
The scores of the 11 specialists were assessed by content
validity analysis: the S-CVI was 0.99, which was coherent.
3.2.2. Cut-off point, Sensitivity, and Specificity
Table 1 shows the DI and YI values determined to
determine the cut-off point as a result of the ROC analysis.
As the cut-off point, where the scale had the highest DI
and YI values, we determined 2.5 points. We measured the
sensitivity of the scale as 1.000 and the specificity of the
scale as 0.942 at this point (Table 2, Figure 2). In order to
reveal the real situation, children with and without nausea
and vomiting were determined in the clinic. For ROC
analysis, children with and without nausea and vomiting
in the clinic were compared. The determined cut-off
point was 3 points because 2.5 points could not be used
in practice. Nausea and vomiting were found to be high
in children with cancer who scored 3 points or more on
the NVTS.
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Table 1. Socio-demographic characteristics of children.
Mean

Standard Deviation

Age

10.68

2.60

Day of Chemotherapy

1.66

0.69

Sex

Diagnosis

Chemotherapy Drugs Used
(A patient is using more than one
medication)

Nausea-Vomiting Type

Vomiting Status
Number of Vomiting (n: 120)

n

%

Girls

147

58.8

Boys

103

41.2

Leukemias

90

36.0

Lymphomas

24

9.6

Solid tumors

20

8.0

Brain tumors

36

14.4

Soft tissue tumors

22

8.8

Bone tumors

58

23.2

Cisplatin

71

28.4

Methotrexate

62

24.0

Ifosfamide-Cyclophosphamide

25

10.0

Vincristine-Vinblastine

21

8.4

Cytarabine

26

10.4

Carboplatin

24

9.6

Etoposide

20

8.0

Other:

11

4.4

Acute nausea-vomiting

180

72

Delayed nausea-vomiting

68

27.2

Anticipatory nausea-vomiting

2

0.8

Yes

120

48.0

No

130

52.0

0-2 times

220

88.0

3-5 times

30

12.0

Table 2. The cut-off point, the estimation values, and the area under the curve (AUC) values for the prediction of nausea and
vomiting according to the ROC analysis.

NVTS

Cut-off
point

Sensitivity

Specificity

P

2.5

1.00

0.942

0.000

AUC*
(%95 CI**)
0.794
(0.737-0.852)

Diagnostic
Index

Youden’s
Index

1.058

0.058

*Area under curve
** Confidence Interval

3.2.3. Predictive Validity
In the linear regression analysis, a model was created
according to the relationship between the variables. In the
model, the chemotherapy drugs, nausea and vomiting type,
vomiting status, and the number of children with cancer
vomiting explained 44.9% of their nausea and vomiting

status. It was determined that children’s chemotherapy
drugs, nausea and vomiting type, vomiting status, and
the number of vomiting children increased the children’s
nausea and vomiting status by as much as 0.777 (β =
0.777), 0.289 (β = 0.289), 1.609 (β = 1.609), and 0.331 (β =
0.331) times, respectively. It was found that all the factors
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that there was a statistically significant difference between
the mean scores of the children with ‘nausea-vomiting‘
and ‘no nausea-vomiting’ for the NVTS in children with
cancer (t=10.412; p<0 .001) (Table 4).
3.3. Reliability Analyses
The ICC between scale was 0.99 (95% CI 0.987 to 0.992)
(Table 5). As a result of the Bland–Altman analysis, the
graph of the differences between the original results of
the two evaluators and the results of the analysis of the
differences are given in Figure 2 and Table 2. Figure 2 shows
that the differences show a homogeneous distribution
around zero and there is not a statistical relationship
between the differences and means. As a result of the
Bland–Altman analysis of the differences, it was found that
the correlation coefficient between the differences and the
means was insignificant (p = 0.226, Table 6). This finding
supports Figure 3.

Figure 2. Determination of the cut-off point according to the
ROC analysis.

had a significant effect on nausea and vomiting status (p <
0.05, Table 3).
3.2.4. Known-Group Comparison
For the known group comparison, the children were asked
whether nausea and vomiting were present at the time of
filling in the scale. The analysis was performed by coding
the children who stated that they had nausea and vomiting
as “1” and those who stated that they did not have nausea
and vomiting as “0”. As a result of the analysis, it was found

4. Discussion
Eleven experts assessed the material validity of the scale,
and the S-CVI was used to determine the views of the
experts. The S-CVI should be above 0.80 in order to
suggest agreement between the experts [22,23]. In this
study, the S-CVI levels were found to be above 0.80. The
S-CVI results showed an agreement between the experts,
the scale accurately assessed the subject, and the validity
of the content was assured. According to the analysis, the
expert scores were coherent. The scale is appropriate for
the Turkish culture.
As a result of the ROC analysis carried out to assess the
cut-off point, we defined 3 points as where the sensitivity
was the highest, and the specificity was the lowest in the
scale. Children with cancer, who had a score of 3 or more

Table 3. The extent to which children with cancer NVTS and the variables.
NVTS
Model 1
β

Coefficients Std.
Error

Standardized
Coefficients Beta

t

p

Chemotherapy Drugs

0.777

0.015

0.252

5.225

0.000

Nausea and Vomiting Type

0.289

0.095

0.156

3.041

0.000

Vomiting Status

1.609

0.160

0.920

10.078

0.000

Number of Vomiting Children

0.331

0.70

0.436

4.718

0.000

R

0.670

R2

0.449

F

49.923

p

0.000

DW* (1.5-2.5)

2.100

*Durbin Watson
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Table 4. Comparison of the average of the high- and low-risk
groups according to the determined cut-off point.
Nausea and
Vomiting Status

Means
X

SD

No

3.65

0.92

Yes

4.63

0.48

t

p

10.412

0.000

compared to that of the NVTS, were evaluated as having a
high nausea and vomiting level.
The ROC curve provided a consistent cut-off point
for the instrument evaluation, and the decisions made
according to this cut-off allowed us to achieve sensitivity
and specificity values. Sensitivity is described as the
“condition in which those who are actually sick are also
sick on the basis of the cut-off point taken during the test.”
Specificity is defined as “the condition in which, as a result
of the test, healthy people are also found to be healthy.”
[24–26]. The curve moves upwards (high sensitivity area)
and to the left (low false positivity area) as the test improves
[24–26]. If the ROC curve (AUC) area is acceptable if
the AUC is between 0.70 and 0.80. It is very good if the
AUC is between .80 and 0.90. If the AUC is above 0.90, it
is excellent [24–26]. It also had the ability to significantly
distinguish the children with and without high nausea and
vomiting levels.
In the literature, it is stated that factors, such as the
type of chemotherapy drug, the chemotherapy protocol,
the type of nausea-vomiting, the vomiting status, and the
number affect the level of nausea and vomiting in children

with cancer [4,5,27,28]. The logistic regression analysis
conducted by Roscoe et al. indicated that expecting
nausea was the strongest predictor (χ 2 = 13.15, p < 0.001)
of actually developing nausea [29]. Our study shows that
the NVTS was effective in the detection of nausea and
vomiting levels for children with cancer. Thus, the NVTS
proved to be a reliable and valid tool for determining
nausea and vomiting.
In this analysis, we expected a significant difference
between the mean nausea and vomiting of children with
and without nausea and vomiting. This study determined
the nausea and vomiting of children according to the
scale cut-off point. The presence of the difference not only
indicated that the scale could significantly determine the
nausea and vomiting of children but also revealed the
construct validity of the scale [18,20,30,31].
An ICC was used to determine the reliability of the
instrument. This indicates the consistency or invariance of
the measurements that an ICC obtains from individuals
at the same or different times. A good fit is considered to
be an ICC above 0.60. In this study, the scale were highly
reliable. The ICC values indicated that the scale measured
the subject sufficiently, the scale was relevant to the subject,
and the scale had quite good reliability [23,32]. Therefore,
the scale in this study is similar to its original construct
and has a strong internal consistency.
As a result of the Bland-Altman analysis of the
differences, it was found that the correlation coefficient
between the differences and the means was insignificant.
The Bland-Altman analysis is a scatter plot where the
difference values between the measurements taken by two
different methods are drawn against the average values

Table 5. Results of the reliability analyses of the scale.
Intraclass
Correlation

95 % CI*

F

Lower Bound

Upper Bound

Value

df

p

Single measures

0.979

0.974

0.984

95.329

249

0.000

Average measures

0.990

0.987

0.992

95.329

249

0.000

* Confidence Interval
Table 6. The results of the analysis of the differences between the original data of the
two evaluators.

Difference

Mean
Difference

df

- .048

249

95% CI* of the
Difference
Lower

Upper

- .1259

.0299

t

p

- 1.213

.226

*Confidence interval.
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Figure 3.
plot: Difference
between thebetween
NVTS’s twothe
evaluators.
Figure
3.Bland-Altman
Bland-Altman
plot: Difference
NVTS's two evaluators

of the same measurements. The difference between the
two measurements and the random distribution of the
differences around “0” provide a generalization of the
research results to the whole group [33,34]. In this study,
it was found that there was no relationship between the
difference values and means of the scale, and it could be
generalized to all children with cancer.
4.1. Limitations
Despite this study’s many strengths, it is limited by
using random sampling, which can affect a study’s
generalizability.
5. Conclusion
The present study revealed that the NVTS is a valid and
reliable instrument to assess the level of vomiting and
nausea experienced by children with cancer. It is thought
to make an important contribution to pediatric oncology
nurses for effective symptom management, through the
creation of a visual scale that evaluates nausea and vomiting.
The NVTS in children with cancer was found to be a valid
and reliable measurement tool for the Turkish sample. This
scale, used in pediatric oncology and hematology clinics in
Turkey, will help nurses to determine nausea and vomiting
in children receiving chemotherapy, and will allow them

to create a common language. It is also expected to be
used comfortably by pediatric oncology nurses as it is a
visual scale. The use of a visual scale will allow rapid and
effective evaluation of nausea and vomiting. NVTS, which
is a visual analog tool, is thought to be a valuable tool,
especially for studies investigating the symptoms of nausea
and vomiting, since it has a very fast and easy application
opportunity.
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